Antidiabetic, Antioxidant, and Gut Microbiota-Modulating Effects of Cymbopogon citratus Leaf Extract in Nicotinamide-Streptozotocin Induced Diabetic Rats

Cymbopogon citratus Leaf Extract (CCE) is used traditionally to manage diabetes mellitus. The study aimed to to evaluate the effects of its oral administration on gut bacteria composition and antidiabetic effect in nicotinamide and streptozotocin-induced diabetic rats. Thirty-five male Wistar rats were divided into five groups comprising 7 rats each. They were; non-diabetic rats given distilled water (PC), untreated diabetic rats (NC), diabetic rats treated with 2.5 mg/kg glibenclamide (RDC), diabetic rats treated with 200 mg/kg extract (CCE1) and diabetic rats treated with 400 mg/kg extract (CCE2). Fasting blood glucose (FBG), insulin, glycogen, lipid profile, catalase, superoxide dismutase (SOD), reduced glutathione (GSH), malondialdehyde (MDA), serum electrolytes, urea, uric acid, creatinine, bilirubin, albumin, alanine and aspartate amino transferases (ALT, AST), alkaline phosphatase (ALP), gut bacterial count were analysed and bacteria identified. Secondary metabolites in extract were also quantified. Results showed significant reductions (p<0.05) in FBG, low density lipoprotein, triglycerides, cholesterol, urea, sodium, catalase, SOD, GSH, and MDA levels in the CCE1 and CCE2 groups compared to the NC. Glycogen, ALT, AST, ALP, and HDL increased significantly. CCE1 outperformed CCE2 in most biochemical parameters. The total bacterial count increased significantly in the treatment groups and the identified species were L. plantarum, L. lactis, C. leptum and, L. mesenteroides. Key secondary metabolites in CCE were catechin, dihydrocytisine, steroid, aphyllidine, Narigenin, proanthocyanidine, oxalate and phytate. In conclusion, CCE exhibited glucose-lowering, antihyperlipidemic, and antioxidant effects, reversed dysfunction in organ function markers and promoted occurrence of beneficial bacterial. Further research into its nutraceutical potential is recommended.

Authors

Institutions

Publication Details

Journal
Biology Medicine & Natural Product Chemistry
Published
2025-12-24
DOI
https://doi.org/10.14421/biomedich.2025.142.1403-1411
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antidiabetic, Antioxidant, and Gut Microbiota-Modulating Effects of Cymbopogon citratus Leaf Extract in Nicotinamide-Streptozotocin Induced Diabetic Rats

Omolola Soji-Omoniwa, Oluwadamilola Elizabeth Britto, Ridwan Tobiloba Bolajoko, Darasimi Deborah Adeosun et al.
Biology Medicine & Natural Product Chemistry
Natural Antidiabetic Agents Studies
article

Antidiabetic, Antioxidant, and Gut Microbiota-Modulating Effects of Cymbopogon citratus Leaf Extract in Nicotinamide-Streptozotocin Induced Diabetic Rats

Omolola Soji-Omoniwa, Oluwadamilola Elizabeth Britto, Ridwan Tobiloba Bolajoko, Darasimi Deborah Adeosun, Celestina Omowunmi Amupitan, Precious Comfort Omogoye, Esther Afifoluwake Orekunrin, Mariam Oyeladun Alimi, Oluwafemi Obed Oluwadare, Emmanuel Ayokanmi Olufemi
article en

Abstract

Cymbopogon citratus Leaf Extract (CCE) is used traditionally to manage diabetes mellitus. The study aimed to to evaluate the effects of its oral administration on gut bacteria composition and antidiabetic effect in nicotinamide and streptozotocin-induced diabetic rats. Thirty-five male Wistar rats were divided into five groups comprising 7 rats each. They were; non-diabetic rats given distilled water (PC), untreated diabetic rats (NC), diabetic rats treated with 2.5 mg/kg glibenclamide (RDC), diabetic rats treated with 200 mg/kg extract (CCE1) and diabetic rats treated with 400 mg/kg extract (CCE2). Fasting blood glucose (FBG), insulin, glycogen, lipid profile, catalase, superoxide dismutase (SOD), reduced glutathione (GSH), malondialdehyde (MDA), serum electrolytes, urea, uric acid, creatinine, bilirubin, albumin, alanine and aspartate amino transferases (ALT, AST), alkaline phosphatase (ALP), gut bacterial count were analysed and bacteria identified. Secondary metabolites in extract were also quantified. Results showed significant reductions (p<0.05) in FBG, low density lipoprotein, triglycerides, cholesterol, urea, sodium, catalase, SOD, GSH, and MDA levels in the CCE1 and CCE2 groups compared to the NC. Glycogen, ALT, AST, ALP, and HDL increased significantly. CCE1 outperformed CCE2 in most biochemical parameters. The total bacterial count increased significantly in the treatment groups and the identified species were L. plantarum, L. lactis, C. leptum and, L. mesenteroides. Key secondary metabolites in CCE were catechin, dihydrocytisine, steroid, aphyllidine, Narigenin, proanthocyanidine, oxalate and phytate. In conclusion, CCE exhibited glucose-lowering, antihyperlipidemic, and antioxidant effects, reversed dysfunction in organ function markers and promoted occurrence of beneficial bacterial. Further research into its nutraceutical potential is recommended.

Biology Medicine & Natural Product ChemistryVol. 14(2)
University of Ilorin (NG)
Openalex Percentile: Top 30%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.